Pierre Gilles holds a PhD in organic chemistry on methodology and natural products synthesis. After a postdoctoral position at the University of Manchester, he joined Edelris, a CRO-company specialized in Med Chem. Then, he worked for Galderma, a pharma group acting in dermatology where he holds a position in med chem and then dev chem. Finally, he has worked for the past 5 years at Protéus, dealing essentially with projects in biocatalysis: set-up of enzymatic reaction and transfer of process to the process development team of the Seqens group.